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1. Introduction 
1.1. Nanotechnology and nanomaterials 
Nanotechnology is a new area that presents small sized materials, structures, devices, and 
systems in last few decades. We hear about many materials and systems that contain 
nanomaterials nowadays. Most of the producers present their products as materials having 
excellent characteristics.  
Due to their small size, nanotechnology based materials have unique characteristics such as 
magnetic, optical, thermal, mechanical, electrical, electron configuration density when 
compared with macromolecules. Nanomaterials are generally at the 1–100 nm scale and 
have a vast range of applications such as in medicine, electronics and energy production. 
Cosmetics, sunscreens, coatings, batteries, fuel additives, paints, pigments, tires and cement 
are the examples of consumer products that based on nanotechnology. Nanomaterials may 
also used for special medical purposes such as to produce novel drug delivery systems, to 
enhance the performance of medical devices, or to produce diagnostic-imaging materials [1]. 
1.2. Nanomedicine 
The European Science Foundation [2] defines ‘Nanomedicine’ as the science and technology 
of diagnosing, treating and preventing disease and traumatic injury, of relieving pain, and 
of preserving and improving human health, using molecular tools and molecular 
knowledge of the human body. It is discussed under five main sub-disciplines as:  
• Analytical tools  
• Nanoimaging 
• Nanomaterials and nanodevices 
• Novel therapeutics and drug delivery systems 
• Clinical, regulatory and toxicological issues. 
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Although most nanotechnology deal with nanoparticles (NPs) sized below 100 nm, in 
nanomedicine including drug delivery systems particle size is ranged from a few 
nanometers to 1000 nm. Nanomedicines in practice are generally sized 5–250 nm [3]. In 
contrast to small sized nanomaterials, this relatively big dimension in drug delivery systems 
is sufficient to load the drugs onto the particles [4].  
1.3. Nanotechnology based novel drug delivery systems 
Nanosized drug delivery systems have already entered routine clinical use and Europe has 
been pioneering in this field [2]. Novel drug delivery systems are improving steadily in 
recent years. Main goals of these improvements are to achieve targetting of drug more 
specifically, to reduce toxicity of drug without the interfering of efficacy, to achieve 
biocompatibility, and to develop safe new medicines [4]. Nanotechnology is extensively 
used to produce the drug carriers having such kind of advantages, for example, carbon 
nanotubes (CNTs) are being used in targeted anticancer drug formulations and it has been 
shown to greatly improve the anticancer activity in animal models. Paclitaxel is another 
extensively studied anticancer molecule of which NP drug delivery formulation is prepared. 
This formulation enhanced cytotoxicity of paclitaxel on tumor cells in vitro and increased 
therapeutic efficacy in an animal model [5]  
Nanomedicines produced with nanotechnology based engineered materials include 
proteins, polymers, dendrimers, micelles, liposomes, emulsions, NPs and nanocapsules [3]. 
2. Nanotoxicology issue of novel drug delivery systems 
2.1. Toxicological aspects of NPs 
Although nanoscale drug delivery systems are designed to reduce toxicity of drugs and to 
increase biocompatibility [6], there maight be some risks because of the unique 
characteristics of them. Due to these challenge, “nanotoxicology” term was adopted and 
defined as the science dealing with the effects of nanodevices and nanostructures in living 
organisms [7]. 
Nanoparticles have intrinsic toxicity profiles. Properties of nanoparticles that might increase 
the toxicity potential include i) particle size, ii) surface area and charge, iii) shape/structure, 
iv) solubility, and v) surface coatings [1]. Small size of NPs give rise to a high surface area 
per unit mass, and this surface area is often correlated with higher biological reactivity. In 
addition, formation of free radicals such as superoxide anion or hydroxyl radical may also 
be increased with high surface area. Accordingly oxidative stress may play an important 
role in NP toxicity especially for metal-based NPs. For example, inflammatory responses to 
NPs can be explained with these free radical formation [8].  
Data on potential human and environmental exposure and dose-response relationship will 
be necessary to determine potential risks of nanomaterials following inhalation, oral or 
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dermal routes of exposure. Significance of dose, dose rate, dose metric, and biokinetics are 
very useful parameters for the safety evaluation of newly engineered NPs. 
One of the most common entry routes for NPs is inhalation. In vivo studies have 
demonstrated lung inflammation as a result of exposure to NPs [9]. Systemic distribution of 
NPs has been reported into the blood stream and lymphatic pathways [10]. 
Another important route for NP entry is the skin, from accidental exposure and use of 
cosmetics and other topical applications. Although the outer layer of the epidermis, the 
stratum corneum, protects against environmental insults, tittanium dioxide (TiO2) has been 
shown to penetrate the stratum corneum and even hair follicles [11]. Penetration of 
nanosized TiO2 (5–20 nm) into the skin and its interaction with the immune system has also 
been demonstrated [12]. 
Dey et al. [13] have demonstrated that nanosized alumina is internalized and significantly 
increases manganese superoxide dismutase (MnSOD) protein levels, indicating that the 
effect of alumina may occur, in part, via alteration of cellular redox status. It was also 
indicated that NP exposure can cause increased proliferation and anchorage-independent 
transformation in JB6 cells. 
De Jong et al. [4] have summarized more striking toxicological effects of NPs in Table 1. 
2.2. Proposed mechanism of NP induced toxicity 
2.2.1. Oxidative stress 
Through many researches, reactive oxygene species (ROS) production is increased at NP 
exposure. This phenomenon is called oxidative stress. Knaapen et al. [14] suggested three 
main factors which cause ROS release: (i) active redox cycling on the surface of NPs, 
particularly the metal-based NPs [15,16] (ii) oxidative groups functionalized on NPs; and 
(iii) particle–cell interactions, especially in the lungs where there is a rich pool of ROS 
producers like the inflammatory phagocytes, neutrophils and macrophages. 
Overproduction of ROS activates cytokines and upregulates interleukin (IL), kinases and 
tumor necrosis factor-α (TNF-α) as an indicators of proinflammatory signaling processes as 
a counter reaction to oxidative stress [17].  
Miura et al. reported that the expressions of ho-1 and mt-2A, well-known oxidative stress 
related genes, were up-regulated by nano-silver treatment. These results indicated that 
apoptosis induction by silver nanoparticles (Ag NPs) may be created by ROS generation [18].  
Potential role of oxidative stress as a mechanism of toxicity of AgNPs were evaluated by 
Hussain et al. [19]. In this study ROS generation following 6 h of exposure to Ag (15, 100 
nm) at 0, 5, 10, 25, and 50 g/mL was investigated. The level of ROS in cells increased in a 
concentration dependent manner and was statistically increased from 10 g/mL 
concentration. Ag (15, 100 nm) treatment at 25 and 50 g/mL resulted in an approximately 10-
fold increase in ROS generation over control levels.  
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Description of finding, in vivo Particle type  
NPs cause pulmonary inflammation in the rat. All PSP 
Later studies show that inflammation is mediated by 
surface area dose. 
SWCNT, MWCNT 
NPs cause more lung tumors than fine particles in rat 
chronic studies. Effect is surface area mediated. 
PSP only. 
NPs cause progression of plague formation (ApoE-/-mice) SWCNT, PM2.5 
NPs affect immune response to common allergens.  Polystyrene, CB, DEP 
NPs can have access to systemic circulation upon 
inhalation and instillation. 
Specific NP, dependent on 
surface coating. 
Description of finding, in vitro  
NPs cause oxidative stress in vivo and in vitro, by 
inflammatory action and generation of surface radicals. 
PSP, NP general, CNT 
NPs inhibit macrophage phagocytosis, mobility and 
killing. 
CB, TiO2 
NPs cause platelet aggregation. 
PM, SWCNT, fullerenes, 
latex-COOH surface 
NPs exposure adversely affects cardiac function and 
vascular homeostasis. 
PM, SWCNT 
NPs interfere with Ca-transport and cause increased 
binding of pro-inflammatory transcription factor NF-kB. 
CB (<100 nm), ROFA, 
PM2.5 
NPs can affect mitochondrial function. Ambient NP 
NPs can translocate to the brain from the nose. MnO2, Au, carbon  
NPs do affect rolling in hepatic tissue. CB 
NP: nano particle, PSP: poorly soluble particles, DEP: diesel exhaust particles, SWCNT: single wall carbon nanotube, 
MWCNT: multi walled carbon nanotube, CB: carbon black, titanium dioxide:TiO2, PM: particulate matter, ROFA: 
residual oil fly ash, manganese dioxide: MnO2, PM2.5: particle mass fraction in ambient air with a mean diameter of 2.5 
µm.  
Table 1. Toxicological effects of engineered and combustion NPs [4]. 
In another study intractions of AgNPs with human fibrosarcoma (HT-1080) and human 
skin/carcinoma (A431) cells was undertaken. When the cells was challenged with AgNPs 
(6.25 µg/mL), signs of oxidative stress such as decrease in oxyradical scavengers including 
reduced glutathione (GSH) and superoxide dismutase (SOD) as well as increase in lipid 
peroxidation were seen. Authors mentioned that observed SOD inactivation might be due to 
generation of peroxy radicals after AgNPs exposure [20]. 
Induction of oxidative stress and apoptosis by AgNPs in the liver of adult zebrafish was 
studied by Choi et.al. The results indicated that the levels of malondialdehyde (MDA), a 
product of cellular lipid peroxidation, and total GSH were increased in the tissues after 
treatment with AgNPs. The mRNA levels of the oxyradical scavenging enzymes catalase 
(CAT) and glutathione peroxidase 1a (GPx 1a) were reduced in the tissues. Authors 
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concluded that the increased level of hepatic MDA indicates that AgNPs induced 
oxyradicals in the liver. In addition, the induction of an endogenous antioxidant, GSH, 
suggests that the liver tissues respond defensively to the increased level of oxyradicals. Also 
the reduction of the levels of CAT and GPx may thus result in the accumulation of hydrogen 
peroxide (H2O2) and other oxyradicals [21]. The elevated oxidative stress can damage lipids, 
carbohydrates, proteins and DNA. 
Some investigations reported that TiO2 increased intracellular ROS generation and MDA 
concentration in a dose-dependent manner [22,23]. The mechanism by which TiO2 NPs can 
generate free radicals is through decreasing the activities of antioxidant enzymes such as 
SOD, CAT, GPx and glutathione reductase (GR) or intracellular levels of antioxidants such 
as GSH and ascorbic acid [24-27].  
Ramkumar et al. reported that the ratio of GSH/GSSG, a good indicator of the levels of 
cellular oxidative stress, was found to be decreased dose dependently in the TiO2 treated 
cells [22] and thus preserving the GSH-mediated antioxidant defense that is critical for cell 
survival. It is possible that the loss of GSH may compromise cellular antioxidant defenses 
and led to the accumulation of ROS and free radicals that are generated in response to 
exposure to NPs or as by products of normal cellular function. 
In line with these findings, Sun et al. investigated the generating of superoxide (O2–.) and 
H2O2 after long-term exposure to TiO2 NPs in mice [28]. Results showed that the production 
rates of O2–. and H2O2 in TiO2 treated group were significantly higher than those of control. It 
is also reported that exposure to TiO2 NPs elicits lipid peroxidation levels in the mouse lung. 
Since ROS act as second messengers in intracellular signaling cascades [29], the increase in 
ROS by TiO2 NPs exposure may play an important role in the modulation of gene 
expression and resultant inflammation or apoptosis. 
Li et al. investigated the oxidative stress associated with gold NPs (Au NPs) in human lung 
fibroblast cells [30]. It was observed that the Au NPs treated cells generated significantly 
more lipid hydroperoxides, a positive indicator of lipid peroxidation, than the control cells. 
In addition, MDA modified protein adducts were evaluated by western blotting as a further 
verification of the presence of lipid peroxidation. MDA reacts readily with protein or DNA 
forming adducts which are considered to be highly genotoxic. The results obtained from this 
study clearly showed that the amount of proteins alkylated by MDA was significantly more 
in the AuNPs treated samples than that in control samples. 
Jia et al. [31] reported that Au NPs can catalyze nitric oxide (NO), a reactive nitrogen 
species, generation from endogenous S-nitroso adducts with thiol group (RSNOs) whenever 
they come into contact with fresh blood serum. RSNOs, such as S-nitrosoalbumin, S-
nitrosocystein and S-nitrosoglutathione, is a more abundant and stable form of NO in blood 
since NO has a relative short lifetime in blood because of its reactivity with various blood 
components. One notable reaction of RSNO dissociation to yield NO is catalyzed by metal 
ions including Au NPs. NO reacts rapidly with O2–. and produces a harmful peroxynitrite 
(ONOO-) species. ONOO- can disrupt lipids, DNA, and proteins.  
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Another study, conducted by Tedesco et al. [32], investigated the oxidative stress and 
toxicity of AuNPs in Mytilus edulis (blue mussel). In this study M. edulis was exposed to 750 
ppb AuNP (average diameter 5.3 ± 1 nm) for 24 hours to investigate in vivo biological effects 
of nanoparticles. Traditional biomarkers and an affinity procedure selective for thiol-
containing proteins were used to study toxic and oxidative stress responses. Protein thiols 
can play a role in antioxidant defense and absorption of ROS. M. edulis that was exposed to 
Au NP were displayed a decreased amount of thiol containing proteins in comparison both 
to controls and those treated with cadmium chloride (CdCl2) (a well known pro-oxidant). 
This result was consistent with direct oxidation of thiols by ROS induced by AuNP. Also 
this was supported by more traditional independent measures of biological and oxidative 
stress such as lysosomal membrane stability and lipid peroxidation. Lysosomal membrane 
stability measured as neutral red retention time showed a decrease for both Au NP and 
CdCl2 treatments confirming significant biological stress. The effect was stronger in the case 
of Au NP than CdCl2. This study also showed that Au NP caused significant lipid 
peroxidation in digestive gland of M. edulis. This study suggested that M. edulis is a suitable 
model animal for environmental toxicology studies of nanoparticles. 
Due to the interesting magnetic and electrical properties with good chemical and thermal 
stabilities, spinal ferrite nanoparticles such as nickel ferrite are used in bioapplications 
including magnetic resonance imaging, drug delivery and hyperthermia [33-37]. However, 
little is known about the toxicity of spinal ferrite nanoparticles at the cellular and molecular 
levels. Ahamed et al. investigated oxidative stress mediated apoptosis induced by nickel 
ferrite nanoparticles in human lung epithelial (A549) cells [38]. In this study the potential of 
nickel ferrite nanoparticles to induce oxidative stress was assessed by measuring the ROS 
and GSH levels in A549 cells. Results showed that the nickel ferrite nanoparticles 
significantly induced the production of ROS and reduced the level of intracellular GSH in 
these cells. Further, co-treatment with the antioxidant L-ascorbic acid migrated the ROS 
generation and GSH depletion due to nickel ferrite nanoparticles exposure. These results 
indicated that nickel ferrite nanoparticles induced oxidative stress in A549 cells by induction 
of ROS and depletion of GSH. 
2.2.2. Phagocytosis of NPs and inflammation 
In respiratory tract, mucociliary clearance removes particulate matter (PM) in <6 µm 
diameter. Alveolar macrophages engulf and process particles that are not cleared by 
mucociliary action and coughing. Upon phagocytosis macrophages are activated to release 
substantial amounts of oxygen radicals, proteolytic enzymes, proinflammatory mediators 
and growth-regulating proteins. These mediators may lead to both acute and chronic lung 
inflammation [17]. 
As other NPs, the toxicity of Ag NPs appears to be driven by their oxidative and 
inflammatory nature, which then drives genotoxic and cytotoxic outcomes [39]. 
Carlson et al. [40], investigated the size-dependent cellular interactions of Ag NPs in rat 
alveolar macrophages (NR8383) cell culture. In this study cells were exposed to 0, 5, 10 and 
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25 µg/mL Ag NPs (15 nm, 30 nm and 55 nm) for 24 hours and levels of characteristic 
markers of macrophage activation such as TNF-α, macrophage inhibitory protein-2 (Mip-2), 
IL-1β and IL-6. The results demonstrated significant levels of TNF-α, Mip-2, IL-1β at 5, 10 
and 25 µg/mL for all sizes of Ag NPs comparing to the control group. However, there was 
no detectable level of IL-6 upon exposure to Ag NPs. Also the cytotoxicity of Ag NPs were 
evaluated by MTT metabolic activity assay (3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) and membrane integrity (lactic dehydrogenase (LDH)) 
assays. The results of the MTT viability assay showed a significant decrease in 
mitochondrial function of alveolar macrophages exposed to Ag NPs at 15 nm, 30 nm, or 55 
nm for 24 h at concentrations ranging from 10 to 75 µg/mL. It was noted that compared to 
the smaller nanoparticles (15 and 30 nm), 55 nm did not exhibit significant toxicity until 50-
75 µg/mL. Similarly to the MTT data, the results of LDH assay showed a dose-dependent 
decrease in cell viability compared to control cells after 24 h of exposure to Ag NPs. Ag NPs 
at 15 and 30 nm exhibited significant cytotoxicity at 10-75 µg/mL, whereas 55 nm required a 
concentration of 75 µg/mL to markedly decrease cell viability according to LDH assay 
results. 
In another study, Park et al. [41] measured secreted NO levels, as a second messenger in 
inflammatory signaling, to investigate the correlation of nitrosative-oxidative stress and 
cytotoxicity induced by Ag NPs. The mouse peritoneal macrophage (RAW264.7) cell line 
were exposed to 0.2, 0.4, 0.8 and 1.6 µg/mL Ag NPs (68.9 nm) for 24, 48, 72 and 96 hours. 
Results showed that NO secretion was increased 2-fold over the control group by Ag NPs at 
1.6 µg/mL. Also TNF-α level was increased almost 2.8-fold and GSH level was decreased by 
the same concentration comparing to control group. Ultimately, the phagocytosis of Ag NPs 
stimulated inflammatory signaling through the ROS generation in macrophages followed by 
the induced secretion of TNF-α. The increase of TNF-α can cause damage of cell membrane 
and apoptosis. Authors concluded that ionization of Ag NPs can be a major factor for all 
these results in cells. 
Park et al. [42] also conducted a 28-day oral administration study in mice to investigate 
toxicity and inflammatory responses of 0.25, 0.5 and 1 mg/kg Ag NPs (42 nm). Evaluation of 
inflammatory responses by repeated administration of AgNPs were conducted by 
measurement of pro-inflammatory cytokines (IL-1, TNF-α and IL-6), Th1-type cytokines (IL-
12 and interferon-gamma), Th2-type cytokines (IL-4, IL-5, IL-10) and transforming growth 
factor beta (TGF-β) concentrations in serum. The results showed that IL-1 was significantly 
increased by Ag NPs. TNF-α and IL-6 were increased almost 2.8-fold and 9.5-fold of the 
control group, respectively. Also both Th1-type cytokines and Th2-type cytokines showed a 
significant increase. TGF-β which is known as tissue damage-related cytokines, was also 
increased in a dose-dependent manner. 
Also some studies reported that exposure to TiO2NPs results in pulmonary inflammation, 
pulmonary edema, macrophages accumulation and pneumonocyte apoptosis [28, 43-45]. 
Jacobsen et al. [46] studied inflammatory potential after intratracheal instillation of 5 
different types of nanoparticles (CB, gold clusters, fullerense C60, SWCNT and quantum 
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dots) for pulmonary effects in apolipoprotein E knockout mice. Results indicated significant 
increases in mRNA levels of Mip-2, IL-6 and macrophages/monocyte chemoattractant 
protein-1 (Mcp-1) in lung tissue following 3h and 24h instillation of SWCNT, CB and 
quantum dots. Also gold and fullerense C60 were found less potent at the three end points 
when compared to others. 
Gosens et al. [47] administered a single dose of 1.6 mg/kg bw of single (50 nm) and 
agglomerated (250 nm) gold particles in the rat lung by intratracheal instillation. Findings 
showed that both single and agglomerated particles were taken up by macrophages. Both 
particles increased inflammatory cells and pro-inflammatory cytokine production. The 
effects were the least for 50 nm Au NPs. 
In line with these findings, Cho et al. [48] reported that Au NPs sized at 13 nm induced 
acute inflammation and apoptosis in the liver of BALB/c mice after intravenous 
administration. 
Downs et al. [49] measured TNF-α and IL-6 in plasma samples of the rats intraperitoneally 
treated with silica NPs (15 nm and 55 nm) and crystalline silica (quartz) particles (400 nm). 
The largest increases in the plasma levels of cytokines were found in the animals exposed to 
125 mg/kg (the highest dose) of both the 15 nm and 55 nm silica NPs and the quartz 
particles. A remarkable increase in the levels of both TNF-α and IL-6 was found in the rats 
treated with the 15 nm silica NPs at 50 mg/kg dose (middle dose), but not at the 25 mg/kg 
dose (low dose). Treatment with the 55 nm silica NPs resulted in a 1.5-fold and a 2.3-fold 
increase in TNF-α and IL-6 levels at 125 mg/kg, respectively, but no change was observed in 
IL-6 levels at the 25 mg/kg doses. Quartz particles showed a 2.3-fold and 2.1-fold induction 
of TNF-α and IL-6 production, respectively, at the 100 mg/kg dose. 
2.2.3. Genotoxicity 
NanoGenotoxicology is yet another new term that was coined to represent the growing 
trend of research into NP-induced genotoxicity and carcinogenesis [17]. Although there is 
still no exact correlation between NP-induced genotoxicity and lung cancer from 
epidemiological studies and in vivo rodent experiments, it is pointed out in literature that 
long-term inflammation and oxidative stress present in tissue can eventually induces DNA 
damage in cells and tissues. Continuous ROS production in the cell can cause gene 
mutations/deletions leading to mutagenesis, carcinogenicity, and subsequently 
development of tumors and cancer. Particularly the metal based NPs like Ag NPs [19], Au 
NPs [30] and TiO2 NPs [22] are important for that kind of ROS production and genetic 
damage. As a result of DNA damage induced by NPs, single-strand DNA breaks, double-
strand breaks, DNA deletions and genomic instability in the form of increase in 8-hydroxy-
2-deoxyguanosine levels are formed [50]. According to Mroz et al.[ 51] long-term exposure 
of cells to NPs displayed genome instability under comet assay analysis, altered cell cycle 
kinetics in flow cytometry and induced protein expression of p53, having a critical role in 
responding to various stresses that cause DNA damage, and DNA repair-related proteins. 
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Li et al. [52] studied the genotoxicity of 5 nm Ag NPs using two standard genotoxicity 
assays, the Salmonella reverse mutation assay (Ames test) and the in vitro micronucleus 
assay. Results demonstrate that 5 nm AgNPs did not induce mutations in five different S. 
typhimurium strains (TA102, TA100, TA1537, TA98 and TA1535). However, Ag NPs 
displayed concentration-dependent genotoxicity in the human lymphoblast TK6 cell 
micronucleus assay. Ag NPs produced statistically significant increases in micronucleus 
frequency in the assay. The data suggest that the in vitro micronucleus assay may be more 
appropriate than the Ames test for evaluating the genotoxicity of the AgNPs. 
Ahamed et al. [53] investigated the ability of uncoated or polysaccharide-coated Ag NPs (25 
nm) to elicit DNA damage within two types of mammalian cells; mouse embryonic stem 
cells (mES) and mouse embryonic fibroblasts (MEF). mES and MEF cell lines were exposed 
to AgNPs at a concentration of 50 µg/mL for a duration of up to 72 hours. Results showed 
that the proteins p53 and Rad51, responsible for DNA double-strand repair, were up-
regulated in two types of mammalian cells. Also in this study DNA double strand breakage 
induced by AgNPs was confirmed by both immunofluorescent and immunoblot analysis of 
phospho-H2AX which is ordinarily induced by DNA double-strand breakage. Results 
indicated that phosphorylation of the histone H2AX were induced by AgNPs. Also this 
study suggested that the polysaccharide coated AgNPs are more individually distributed 
and exhibited more severe damage than uncoated AgNPs. This finding may be related with 
the agglomeration of the uncoated particles and restriction of their cellular distribution. 
In an in vivo study, Kim et al. [54] conducted a 90-day whole-body inhalation study (6 hours 
day/5 days a week) to AgNPs (18 nm) in rats at low (0.7 × 106 particles/cm3), middle (1.4 × 
106 particles/cm3) and high (2.9 × 106 particles/cm3) doses. After sacrificing of rats, 
micronucleus induction was measured in the bone marrow according to the test guideline 
474 issued by OECD. Authors found out that AgNPs did not affect either the frequency of 
micronucleated polychromatic erythrocytes (PCE) as an indicator of DNA damage or the 
PCE / (PCE+NCE) ratio as an indicator of toxicity to bone marrow cells (NCE: 
normochromatic erythrocytes) in male and female rats. The authors concluded that 
exposure to AgNPs by inhalation for 90 days does not induce genetic toxicity in male and 
female rat bone marrow in vivo. 
Also the same authors conducted an in vivo micronucleus assay after 28-day oral 
administration of Ag NPs. The results were similar to those of inhalation study [55]. 
A number of studies have shown that TiO2 NPs exhibited genotoxicity in cultured cell lines 
[56-58]. Kang et al. [59], studied the genotoxic effects of TiO2 NPs (20-100 µg/ml) in human 
peripheral blood lymphocyte cells using alkaline single cell gel electrophoresis (Comet) and 
cytokinesis block micronucleus (CBMN) assays. The CBMN assay results showed that the 
micronuclei frequency increased in a dose-dependent manner. Also cells had a significant 
olive tail moment which indicates unrepaired DNA strand breaks in comet assay. 
Similarly, Wang et al. [60] investigated the toxicity of ultrafine TiO2 particles in cultured 
human B-cell lymphoblastoid cell line (WIL2-NS). Significant increases in the micronuclei 
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frequency were detected by the CBMN assay in a dose-dependent manner. In the comet 
assay, 3-fold increase in %Tail DNA were found when the cells were treated with ultrafine 
TiO2 at a dose of 65 µg/mL for 24 hours exposure. In the olive tail moment a 5-fold elevation 
was found at the same dose and exposure duration. Also a linear relationship was 
determined between the mutation frequency and concentration in the clonal selection assay 
for the hypoxanthine-guanine phosphoribosyl transferase (HPRT) gene. 
Toyooka et al. [61] examined the genotoxicity of TiO2 NPs (5 nm) and microparticles (<5000 
nm) in the lung adenocarcinoma epithelial cell line (A549) based on the phosphorylation of 
histone H2AX (γ-H2AX) as a new sensitive biomarker for DNA damage. Results showed 
that TiO2 particles have the ability to generate γ-H2AX and this was more remarkable with 
nanoparticles than microparticles. 
Contrary to above studies, a number of investigations showed that TiO2 NPs didn’t induce 
DNA damage and mutation using the Ames test, micronucleus assay, comet assay, and etc. 
[62-68]. 
Au NPs are also recognized in their ability to contribute in genotoxicity. Schulz et al. [69] 
investigated two genotoxic endpoints, alkaline comet assay in lung tissue and 
micronucleation in PCE of the bone marrow, 72 hours after a single instillation of 18 µg 
uncoated Au NPs in different sizes (2, 20 and 200 nm) into the trachea of male adult Wistar 
rats. Results indicated that AuNPs in the different sizes were non-genotoxic and showed no 
systemic and local adverse effects at the given dose. 
Also the genotoxicity of zinc oxide nanoparticles (ZnO NPs), widely used in cosmetics and 
sunscreens, was evaluated in some studies. Sharma et al. [70] investigated the genotoxicity 
of these nanoparticles in primary human epidermal karatinocytes using comet assay. 
Results showed a significant induction in DNA damage in cells exposed to 8 and 14 µg/mL 
ZnO NPs for 6 hours comparing to control group. Finding demonstrated that ZnO NPs are 
assimilated by the human epidermal karatinocytes and induce cytotoxic and genotoxic 
responses. 
Also in another study Sharma et al. [71] highlighted the in vitro genotoxicity of ZnO NPs in 
human liver cells (HepG2). Similarly significant increase in DNA damage was observed in 
cells in the comet assay. 
Fen Song et al. [50] analyzed the induction of reticulocyte micronuclei and oxidative DNA 
damage in ICR female mice after intraperitoneal injection of metal oxides (CuO, Fe2O3, 
Fe3O4, TiO2) and Ag NPs at various doses (0, 1, 3 mg/mouse). The results of the 
micronucleus assay demonstrated significant increases in micronucleated reticulocyte 
formation after the intraperitoneal administration of CuO, Fe2O3, Fe3O4, TiO2 and Ag NPs. 
Also the levels of 8-hydroxydeoxyguanosine (8-OH-dG) which is one of the most well 
studied biomarkers to measure the oxidative damage in DNA was evaluated in liver and 
bone marrow DNA and urine after the administration of metal oxide and Ag NPs. The 
urinary level of 8-OH-dG was significantly increased by the CuO at each time point of the 
urine analysis. Although the increases in the urinary levels of 8-OH-dG for the other 
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nanoparticle treatments were not significant, all of the other metal compounds showed 
higher levels of urinary 8-OH-dG than the control. The 8-OH-dG levels in the bone 
marrow immediately increased after the injection of CuO, and continued to increase up to 
24 h after administration. Also the 8-OH-dG levels in the liver DNA of the mice treated 
with 3 mg CuO were significantly higher than those in the non-treated control. The 
increase of 8-OH-dG levels in the liver DNA continued for 72 h after the administration of 
1 and 3 mg doses of CuO. The other nanoparticles did not cause an increase in the liver 8-
OH-dG level at 24 h after administration. Authors concluded that metal oxide 
nanoparticles can cause genotoxic effects in vivo. Among them, the CuO NPs were the 
most potent, iron oxide NPs also showed relatively high toxicity and TiO2 and Ag NPs 
showed low toxicity. 
3. Toxicity assessment of novel drug delivery systems 
Lack of full toxicological knowledge about nanomaterials including novel drug delivery 
systems lead  to  the misperception regarding all nanomaterials pose a significant health 
risk. Under such realistic conditions, many engineered NPs are unlikely to induce adverse 
effects although effects of chronic and low level exposures are still largely unknown. Owing 
to extensive toxicological studies it will be possible to do exact risk assessment related with 
NPs. 
Identification of potential health risks is a prerequisite for assessing the safety of the new 
products that are being developed. That is why, nanotoxicology area is gaining increasing 
importance with the growth of nanotechnological applications. Safety evaluation of 
nanomaterials through toxicological research will also provide information about their 
undesirable properties. These information will also help to avoid their possible adverse 
effects [7]. 
Toxicity studies on nanoparticles are generally conducted at very high doses. With high 
doses, any NP can be identified as toxic in living systems. A more realistic approach will be 
to discriminate high doses tested and tests under real exposure conditions. Therefore non in 
vivo assays for the purpose of extrapolating the responses to in vivo results may reduce and 
avoid a lot of laboratory animals. Beside occupational exposure to NP where they are 
produced and intentional use of consumer goods containing NP should be evaluated. With 
respect to nanomedicine, in vivo tests will always be mandatory for nanotechnology-based 
therapeutics and diagnostics [72]. 
As mentioned by Oberdorster [72], a tiered testing system to assess NP toxicity was 
suggested by a working group of the International Life Sciences Institute (ILSI) [73]. 
Table 2 lists the tiered testing strategy including physico-chemical characterization 
prior to and during testing in cell-free, cellular and in vivo assays. Studies designed to 
determine whether in vitro assays are predictive for in vivo effects have come to opposite 
conclusions. 
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4. Dose concepts in NP toxicology 
Classical mass dose trend applied in conventional toxicological research may not be 
sufficient in nanotoxicological testing due to the extensively large surface area compairing 
with large particles. Oberdorster [74] studied the toxicity of ultrafine and fine TiO2 
measuring polymorphonuclear neutrophils in lung lavage fluid as an index of inflammation 
and they found ultrafine TiO2 as more toxic than fine TiO2 considering mass unit dose. 
When considered surface area, the toxicity was equivalent. 
• Physico-chemical characterization
• Cell-free assays (solubility; ROS generating potential; chemreactivity; 
agglomeration ⁄ aggregation; zeta potential; other)
• Cellular assays [primary cells; cell-lines; (primary and
secondary organs); co-cultures]
• In vivo assays [generally rodents; diverse methodologies
(resp. tract; skin; GI-tract)]
• Question
Can any of the in vitro tests be used to predict in vivo toxicity?
Table 2. Tiered testing system to assess NP toxicity (ILSI Report) [73] 
In vivo and in vitro test correlation is critical point in safety evaluations. The dose unit 
considered in the evaluations may affect the correlations between in vitro and in vivo tests 
directly. Say et al. studied fine and nanoparticle toxicity assessing in alveolar macrophages 
and a pulmonary epithelial cell line and then comparing them with the in vivo pulmonary 
inflammation induced by the same particles in rats [75]. They could not find a significant in 
vitro – in vivo correlation and suggested more sophisticated in vitro cell culture systems to 
gauge the relative toxicity of nanoparticles in vivo. When these results were analyzed 
according to the new approach suggested by Rushton et al. [76] who used NP surface area 
as a dose unit, the in vitro and in vivo results of Say et al. were correlated significantly.  
5. Conclusion 
As said by Oberdorster [72], nanotechnology, nanomedicine and nanotoxicology are closely 
related disciplines aimed at the improvement of human life. As a result of introducing of 
nanotechnology based nanomaterial into nanomedicine, novel and superior diagnostic, 
therapeutic and preventive systems have emerged. The safety assessment of these new 
materials is mandatory to recognize risks and avoid potential hazards. This assessment also 
provide useful information to avoid disinformation about the toxicity potential of nanosized 
systems. At this point nanotoxicology will have a crucial role. Material scientists, physicians, 
pharmacists and toxicologists should be included in nanotechnological developments as a 
team aproach. 
As a result, it is important that safety assessments and health risks of novel drug delivery 
systems including nanomaterials should be made with the available and produced data. 
Nanomaterials should be evaluated on case-by-case basis in place of general evaluations for 
NPs. 
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